Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025)
Siga Technologies (SIGA) reported Total Non-Current Liabilities of $18.0 million for Q4 2025, down 28.97% on a YoY basis from $25.3 million in Q4 2024, and down 27.57% quarter-over-quarter from $24.8 million in Q3 2025.
Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends
Siga Technologies has reported Total Non-Current Liabilities for 16 years, with the latest figure at $18.0 million in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities fell 28.97% year-over-year to $18.0 million; the trailing twelve-month figure through Dec 2025 stood at $18.0 million (down 28.97% YoY), and the FY2025 full-year result was $18.0 million, down 28.97% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $18.0 million, down from $24.8 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $74.8 million in Q1 2024, with the low at $10.4 million in Q1 2021.
- Historically, Total Non-Current Liabilities has averaged $26.0 million across 5 years, with a median of $22.5 million in 2021.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 304.9% — and 2025, when it sank 62.84%.
- Siga Technologies' Total Non-Current Liabilities stood at $33.9 million in 2021, then sank by 36.51% to $21.5 million in 2022, then surged by 151.5% to $54.1 million in 2023, then slumped by 53.19% to $25.3 million in 2024, then dropped by 28.97% to $18.0 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $18.0 million (Q4 2025), $24.8 million (Q3 2025), and $22.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | 17.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 24.84 Mn |
| Jun 30, 2025 | 22.72 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 25.33 Mn |
| Sep 30, 2024 | 22.30 Mn |
| Jun 30, 2024 | 21.38 Mn |
| Mar 31, 2024 | 74.81 Mn |
| Dec 31, 2023 | 54.12 Mn |
| Sep 30, 2023 | 30.74 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 21.52 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | 20.17 Mn |
| Mar 31, 2022 | 10.64 Mn |
| Dec 31, 2021 | 33.89 Mn |
| Sep 30, 2021 | 22.66 Mn |
| Jun 30, 2021 | 13.25 Mn |
| Mar 31, 2021 | 10.36 Mn |